Published November 1, 2019, in the American Journal of Managed Care by Robert Gagel, MD Robert Gagel, MD, is chair of the Board at the National Osteoporosis Foundation. He is a professor of medicine at MD Anderson Cancer Center and an adjunct professor in the Departments of Medicine and Cell Biology at Baylor College of… Read more »
Osteoporosis in the News
May is National Osteoporosis Month »
The National Osteoporosis Foundation (NOF) launches new resources including interactive digital tool, podcast and first-of-its-kind patient registry in honor of 35th Anniversary ARLINGTON, VA (April 22, 2019) — NOF is celebrating National Osteoporosis Month in May and its 35th Anniversary with the launch of new resources designed to help people of all ages understand the… Read more »
FDA Approves EVENITY™ (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture »
One in Two Women in the United States Will Suffer a Fracture in Her Lifetime Due to Osteoporosis(1) EVENITY is the First and Only Bone Builder With a Dual Effect That Both Increases Bone Formation and Decreases Bone Loss(2) EVENITY Rapidly Reduces Fracture Risk and Builds New Bone With 12 Months of Therapy(2) THOUSAND OAKS,… Read more »
Bindex Measurement Revolutionizes Osteoporosis Diagnostics in US »
Bone Index Ltd., a medical device company with game-changing point-of-care technology (Bindex®) in osteoporosis diagnostics, announces that one million patients have been measured with Bindex® in the U.S. in 2018. Earlier this year, the American Medical Association issued a new reimbursement code* for Bindex® and the Centers for Medicare & Medicaid Services (CMS) has approved… Read more »
NOF Response to NPR Article – Wider Use Of Osteoporosis Drug… »
“This is an extremely important paper,” says Dr. Ethel Siris, a Columbia University medical professor who specializes in thinning bones and wasn’t involved in the study. “We now know that we have a therapy that has been shown to be highly effective.” “This could prevent a lot of fractures,” says Siris, who is on the… Read more »
New York Times Article: Your Lifetime Health Check Up Roadmap »
This recent New York Times article details the routine screening exams you should undergo to catch health problems at any age, including asking for a bone density test in your 60’s. Many of the leading killers of Americans are chronic diseases that can be prevented with healthy habits like a good diet and plenty of… Read more »
NPR Article: Wider Use Of Osteoporosis Drug Could Prevent Bone Fractures In More Elderly Women »
In response to a recent NPR article detailing the positive results of a common osteoporosis drug, Elizabeth Thompson, NOF, CEO, said: “When the experts in the field say that this study is “extremely important”, “highly effective”, and “a breakthrough”, we are making progress! Reducing suffering and maintaining life quality is important for our senior population—key… Read more »
NOF Named an Official Charity Partner of the TCS New York City Marathon and Fields a Team of Runners Aged 40+ »
The National Osteoporosis Foundation (NOF), the leading bone health organization in the U.S., was named an Official Charity Partner of the 2018 TCS New York City Marathon. The race will take place on Sunday, November 4, 2018. For its inaugural team, NOF has secured five women over the age of 40 to join its Be… Read more »
Leading Organizations Meet To Discuss Unmet Needs In Osteoporosis and Outline An Initial Action Plan »
June 11, 2018| Press Releases On June 11, 2018, leaders from the National Osteoporosis Foundation (NOF), International Osteoporosis Foundation (IOF), and Amgen’s Bone Health and Advocacy Relations teams convened in London, England at the Royal Academy of Medicine. The purpose of the meeting was to develop a concrete plan for a meaningful collaboration between the two organizations. Back row:… Read more »
NOF Statement on New Treatment Option for Glucocorticoid-Induced Osteoporosis (GIOP) »
GIOP is the most common form of secondary osteoporosis. In the U.S., more than 10 percent of patients who receive long-term glucocorticoid treatment are diagnosed with a clinical fracture. The U.S. Food and Drug Administration (FDA) has recently approved the use of denosumab for the treatment of glucocorticoid-induced osteoporosis (GIOP) in men and women at… Read more »